Phase III XELOX trial in metastatic colorectal cancer meets primary endpoints

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2006年 / 20卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1871 / 1872
页数：2
相关论文
共 50 条
  • [21] Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer
    Conroy, T.
    Hebbar, M.
    Bennouna, J.
    Ducreux, M.
    Ychou, M.
    Lledo, G.
    Adenis, A.
    Faroux, R.
    Rebischung, C.
    Kockler, L.
    Douillard, J. Y.
    BRITISH JOURNAL OF CANCER, 2010, 102 (01) : 59 - 67
  • [22] Survival and response results from XELOX-1/NO16966: a randomized phase III trial of XELOX vs. FOLFOX4 as first-line treatment for patients with metastatic colorectal cancer (MCRC)
    Cassidy, J.
    Clarke, S.
    Diaz-Rubio, E.
    Scheithauer, W.
    Figer, A.
    Wong, R.
    Koski, S.
    Lichinitser, M.
    Yang, T.
    Saltz, L.
    ANNALS OF ONCOLOGY, 2007, 18 : VII19 - VII19
  • [23] Phase II trial of edatrexate in patients with metastatic colorectal cancer
    Clamon, GH
    Riggs, CE
    Dreicer, R
    Hohl, RJ
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (04) : 359 - 361
  • [24] A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
    A. Sabharwal
    P. G. Corrie
    R. S. Midgley
    C. Palmer
    J. Brady
    P. Mortimer
    A. J. Watson
    G. P. Margison
    M. R. Middleton
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 829 - 835
  • [25] A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
    Sabharwal, A.
    Corrie, P.
    Seebaran, A.
    Anderson, D.
    Carmichael, J.
    Mortimer, P.
    Margison, G. P.
    Watson, A.
    Middleton, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
    Khan, O. A.
    Ranson, M.
    Michael, M.
    Olver, I.
    Levitt, N. C.
    Mortimer, P.
    Watson, A. J.
    Margison, G. P.
    Midgley, R.
    Middleton, M. R.
    BRITISH JOURNAL OF CANCER, 2008, 98 (10) : 1614 - 1618
  • [27] A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
    O A Khan
    M Ranson
    M Michael
    I Olver
    N C Levitt
    P Mortimer
    A J Watson
    G P Margison
    R Midgley
    M R Middleton
    British Journal of Cancer, 2008, 98 : 1614 - 1618
  • [28] A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
    Sabharwal, A.
    Corrie, P. G.
    Midgley, R. S.
    Palmer, C.
    Brady, J.
    Mortimer, P.
    Watson, A. J.
    Margison, G. P.
    Middleton, M. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 829 - 835
  • [29] Phase III trial of chemotherapy ? HerceptinR in metastatic breast cancer
    Cardoso F.
    Breast Cancer Research, 3 (1)
  • [30] Xelox: A good alternative for a better compliance in metastatic colorectal cancer patients
    Muggiano, A.
    Mulas, C.
    Fiori, B.
    Liciardi, G. F.
    Pintus, M.
    Tanca, L.
    Tedde, A.
    Turno, R.
    Desogus, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 45 - 45
12345